1 / 6

Age (years) Gender (Males), n (%) Dialysis duration (years) Hemoglobin (mg / dl)

Table 1. Characteristics of patients with and without CMBs, and healthy subjects a. P Value b. Healthy subjects (n=58). Total (n=179). Without CMBs (n=134). With CMBs (n=45). 67.1 ± 10.3 28 (62.2%) 5.9 ± 6.6 10.5 ± 1.3 159.0 ± 19.4 77.8 ± 12.1 149.2 ± 24.1 75.9 ± 12.8 --- ---

liona
Télécharger la présentation

Age (years) Gender (Males), n (%) Dialysis duration (years) Hemoglobin (mg / dl)

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Table 1. Characteristics of patients with and without CMBs, and healthy subjectsa P Valueb Healthy subjects (n=58) Total (n=179) Without CMBs (n=134) With CMBs (n=45) 67.1 ± 10.3 28 (62.2%) 5.9 ± 6.6 10.5 ± 1.3 159.0 ± 19.4 77.8 ± 12.1 149.2 ± 24.1 75.9 ± 12.8 --- --- 43 (95.6 %) 38 (84.4 %) 3.8 ± 2.3 20 (44.4 %) 160.1 ± 38.5 100.6 ± 54.7 47.4 ± 14.3 24 (53.3 %) 16 (35.6 %) 10 (22.2 %) 3.7 ± 0.5 0.334 ± 0.488 19 (42.2 %) --- < 0.0001 NS NS NS < 0.0001 NS 0.0051 NS --- --- 0.0443 NS NS 0.0340 NS NS NS NS NS NS NS NS NS --- 58.2 ± 13.6 114(63.7%) 7.2 ± 7.6 10.6 ± 1.4 148.5 ± 21.5 76.0 ± 12.3 140.4 ± 24.6 75.1 ± 14.2 --- --- 154 (86.0 %) 134 (74.9 %) 4.1 ± 2.4 55(30.7 %) 161.4 ± 37.9 118.0 ± 74.7 48.7 ± 15.1 86 (48.0 %) 60 (33.5 %) 39 (21.8 %) 3.8 ± 0.5 0.330 ± 0.604 70 (39.1 %) 45 (25.1 %) 55.2 ± 13.4 86 (64.2%) 7.6 ± 7.9 10.6 ± 1.4 144.7 ± 21.0 75.3 ± 12.4 137.4 ± 24.2 74.8 ± 14.7 --- --- 111 (82.8 %) 96 (71.6 %) 4.2 ± 2.5 35 (26.1 %) 161.8 ± 37.9 123.7 ± 79.5 49.2 ± 15.4 62 (46.3 %) 44 (32.8 %) 29 (21.6 %) 3.8 ± 0.5 0.327 ± 0.639 51 (38.1 %) --- Age (years) Gender (Males), n (%) Dialysis duration (years) Hemoglobin (mg / dl) Pre dialysis SBP (mmHg) Pre dialysis DBP(mmHg) Post dialysis SBP (mmHg) Post dialysis DBP (mmHg) SBP (mmHg) DBP (mmHg) Hypertension, n (%) Use of antihypertensive agents, n (%) Interdialytic body weight gain(%) Diabetes mellitus, n (%) Total cholesterol (mg / dl) Triglycerides (mg / dl) HDL cholesterol (mg / dl) Dyslipidemia, n (%) Ischemic heart disease, n (%) Current smoking, n (%) Serum albumin (g / dl) C-reactive protein (mg / dl) Use of antithrombotic agents, n (%) Prevalence of CMBs, n (%) 55.9 ± 9.5 31 (53.4%) --- 13.8 ± 1.4 --- --- --- --- 122.4 ± 16.5 77.6 ± 11.1 10 (17.2 %) 3 (5.2 %) --- 1 (1.7 %) 208.1 ± 28.8 108.3 ± 56.4 67.1 ± 18.5 25 (43.1 %) 0 (0 %) 10 (17.2 %) 4.2 ± 0.2 0.138 ± 0.129 0 (0 %) 0 (0 %) CMBs, cerebral microbleeds; SBP, systolic blood pressure; DBP, diastolic blood pressure; HDL, high density lipoprotein; PVH, periventricular hyperintensity; DSWMH, deep and subcortical white matter hyperintensity. aPlus-minus values are mean ± SD, bwithout CMBs versus with CMBs

  2. Table 2. Univariate logistic regression analysis of factors associated with CMBs Univariate Variable P Unit Increase Odds Ratio (95% CI) Age 1 year Gender Dialysis duration 1 year Predialysis systolic blood pressure 1 mmHg Pre dialysis diastolic blood pressure 1 mmHg Postdialysis systolic blood pressure 1 mmHg Postdialysis diastolic blood pressure 1 mmHg Hypertension Use of antihypertensive agents Interdialytic body weight gain 1 % Diabetes mellitus Dyslipidemia Ischemic heart disease Current smoking Serum albumin 1 g / dl C-reactive protein 1 mg / dl Hemoglobin 1 g / dl Use of antithrombotic agents 1.092 (1.052 - 1.133) 0.919 (0.457 - 1.849) 0.967 (0.921 - 1.016) 1.037 (1.018 - 1.057) 1.017 (0.989 - 1.045) 1.020 (1.005 - 1.034) 1.006 (0.982 - 1.030) 4.455 (1.007 - 19.714) 2.149 (0.883 - 5.230) 0.939 (0.814 - 1.083) 2.263 (1.120 - 4.571) 1.327 (0.674 - 2.612) 1.129 (0.555 - 2.293) 1.034 (0.458 - 2.335) 0.751 (0.379 - 1.489) 1.020 (0.585 - 1.779) 0.970 (0.757 - 1.243) 1.189 (0.598 - 2.363) <.0001 .8133 .1873 .0001 .2423 .0066 .6298 .0490 .0919 .3839 .0228 .4125 .7382 .9350 .4126 .9440 .8098 .6207 Dummy variables were entered for gender (female = 0, male = 1), presence of CMBs (absent = 0, present = 1), hypertension (absent = 0, present = 1), diabetes mellitus (absent = 0, present = 1), dyslipidemia (absent = 0, present = 1), ischemic heart disease (absent = 0, present = 1), current smoking (non-smoker = 0, smoker = 1), use of antihypertensive agents (no = 0, yes = 1) and antithrombotic agents(no = 0, yes = 1).

  3. Table 3. Multiple logistic regression analysis of factors associated with CMBs Model 3 Model 1 Model 2 Variable Odds Ratio (95% CI) Unit Increase Odds Ratio (95% CI) Odds Ratio (95% CI) Age 1 year Gender Dialysis duration 1 year Diabetes mellitus Dyslipidemia Ischemic heart disease Current smoking Serum albumin 1 g / dl C-reactive protein 1 mg / dl Hemoglobin 1 g / dl Use of antithrombotic agents Interdialytic body weight gain 1 % Pre dialysis systolic blood pressure 1 mmHg Pre dialysis diastolic blood pressure 1 mmHg Hypertension 1.100 ****(1.052 - 1.150) 0.758 (0.294 - 1.957) 1.001 (0.940 - 1.066) 1.522 (0.612 - 3.787) 1.190 (0.515 - 2.750) 0.834 (0.328 - 2.118) 1.477 (0.530 - 4.116) 1.442 (0.545 - 3.815) 0.888 (0.405 - 1.947) 1.091 (0.782 - 1.524) 0.787 (0.309 - 2.004) 0.982 (0.822 - 1.173) 1.037***(1.015 - 1.058) --- --- 1.117**** (1.066 - 1.170) 0.673 (0.266 - 1.701) 0.993 (0.935 - 1.053) 1.874 (0.761 - 4.619) 1.336 (0.583 - 3.062) 0.917 (0.362 - 2.322) 1.518 (0.562 - 4.104) 1.334 (0.515 - 3.457) 0.836 (0.387 - 1.852) 0.998 (0.724 - 1.376) 0.670 (0.270 - 1.665) 1.007 (0.850 - 1.194) --- 1.054** (1.016 - 1.094) --- 1.095 ****(1.052 - 1.141) 0.739 (0.300 - 1.824) 0.992 (0.935 - 1.053) 1.256 (0.516 - 3.053) 1.150 (0.513 - 2.582) 0.741 (0.300 - 1.833) 1.314 (0.497 - 3.474) 1.257 (0.499 - 3.167) 0.836 (0.397 - 1.762) 1.043 (0.759 - 1.433) 0.828 (0.344 - 1.994) 0.990 (0.835 - 1.173) --- --- 3.460 (0.707 - 16.917) R2 0.237**** 0.214**** 0.186*** Dummy variables were entered for gender (female = 0, male = 1), presence of CMBs (absent = 0, present = 1), diabetes mellitus (absent = 0, present = 1), dyslipidemia (absent = 0, present = 1), ischemic heart disease (absent = 0, present = 1), current smoking (non-smoker = 0, smoker = 1), hypertension (absent = 0, present = 1) and use of antithrombotic agents(no = 0, yes = 1). R2 ; coefficient of determination. **** P < 0.0001, ***P < 0.001, * *P < 0.01, * P < 0.05

  4. Table 4. Multiple logistic regression analysis of factors associated with CMBs Model 6 Model 4 Model 5 Variable Odds Ratio (95% CI) Unit Increase Odds Ratio (95% CI) Odds Ratio (95% CI) Age 1 year Gender Dialysis duration 1 year Diabetes mellitus Dyslipidemia Ischemic heart disease Current smoking Serum albumin 1 g / dl C-reactive protein 1 mg / dl Hemoglobin 1 g / dl Use of antithrombotic agents Interdialytic body weight gain 1 % Post dialysis systolic blood pressure 1 mmHg Post dialysis diastolic blood pressure 1 mmHg Use of antihypertensive agents 1.102 ****(1.055 - 1.152) 0.725 (0.292 - 1.799) 0.999 (0.941 - 1.060) 1.674 (0.689 - 4.066) 1.168 (0.515 - 2.647) 0.741 (0.300 - 1.831) 1.181 (0.437 - 3.188) 1.440 (0.561 - 3.700) 0.864 (0.400 - 1.867) 1.071 (0.777 - 1.476) 0.836 (0.342 - 2.040) 1.037 (0.870 - 1.237) 1.023*(1.005 - 1.040) --- --- 1.129**** (1.073 - 1.188) 0.750 (0.302 - 1.863) 0.996 (0.938 - 1.058) 1.755 (0.721 - 4.276) 1.286 (0.563 - 2.938) 0.782 (0.313 - 1.951) 1.199 (0.440 - 3.272) 1.328 (0.519 - 3.395) 0.991 (0.462 - 2.124) 1.039 (0.749 - 1.441) 0.789 (0.323 - 1.928) 1.024 (0.860 - 1.221) --- 1.050** (1.015 - 1.086) --- 1.106 ****(1.059 - 1.155) 0.693 (0.281 - 1.705) 0.988 (0.932 - 1.047) 1.109 (0.439 - 2.801) 1.107 (0.492 - 2.493) 0.731 (0.297 - 1.804) 1.372 (0.517 - 3.644) 1.397 (0.548 - 3.560) 0.920 (0.439 - 1.926) 1.072 (0.774 - 1.486) 0.750 (0.309 - 1.821) 1.002 (0.846 - 1.186) --- --- 2.756 (0.932 - 8.149) R2 0.206**** 0.214**** 0.190*** Dummy variables were entered for gender (female = 0, male = 1), presence of CMBs (absent = 0, present = 1), diabetes mellitus (absent = 0, present = 1), dyslipidemia (absent = 0, present = 1), ischemic heart disease (absent = 0, present = 1), current smoking (non-smoker = 0, smoker = 1), hypertension (absent = 0, present = 1), use of antithrombotic agents(no = 0, yes = 1) and antihypertensive agents (no = 0, yes = 1). R2 ; coefficient of determination. **** P < 0.0001, ***P < 0.001, * *P < 0.01, * P < 0.05

  5. Table 5. Prevalenceof cerebral small-vessel diseases with and without CMBs P Valuea Total (n=179) Without CMBs (n=134) With CMBs (n=45) 29 (64.4 ) 38 (84.4 ) 35 (77.8 ) 45 (33.6 ) 41 (30.6 ) 49 (36.6 ) 74 (41.3 ) 79 (44.1 ) 84 (46.9 ) 0.0005 < 0.0001 < 0.0001 Lacunar infarcts, n (%) PVH , n (%) DSWMH , n (%) CMBs, cerebral microbleeds; PVH, periventricular hyperintensity; DSWMH, deep and subcortical white matter hyperintensity. awithout CMBs versus with CMBs

  6. Table 6. Correlations between CMBs and other cerebral small-vessel diseases Unadjusted Adjusted* Variable P P Odds Ratio (95% CI) Odds Ratio (95% CI) 3.585 (1.766 - 7.276) 12.314 (5.077 - 29.866) 6.071 (2.767 - 13.323) Lacunar infarcts PVH DSWMH .0004 < .0001 < .0001 1.707 (0.764 - 3.814) 7.442 (2.919 - 18.974) 3.630 (1.567 - 8.410) .1921 < .0001 .0026 CMBs, cerebral microbleeds; PVH, periventricular hyperintensity; DSWMH, deep and subcortical white matter hyperintensity; 95% CI, 95% confidence interval. Dummy variables were entered for presence of CMBs (absent = 0, present = 1), lacunar infarcts (absent = 0, present = 1), PVH (absent = 0, present = 1 and DSWMH (absent = 0, present = 1). *Adjusted by age and gender

More Related